相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2020)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Bohm et al.
LANCET (2020)
Device-based therapies for arterial hypertension
Lucas Lauder et al.
NATURE REVIEWS CARDIOLOGY (2020)
Renal Denervation in High-Risk Patients With Hypertension
Felix Mahfoud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2020)
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2019)
Cardiac magnetic resonance assessment of central and peripheral vascular function in patients undergoing renal sympathetic denervation as predictor for blood pressure response
Karl Fengler et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy Lost, and Then Found, in Translation
John W. Osborn et al.
HYPERTENSION (2018)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari et al.
LANCET (2018)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi et al.
LANCET (2018)
Renal sympathetic nerve activity after catheter-based renal denervation
Linn C. Dobrowolski et al.
EJNMMI RESEARCH (2018)
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend et al.
LANCET (2017)
Regression to the Mean in SYMPLICITY HTN-3 Implications for Design and Reporting of Future Trials
Stuart J. Pocock et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension
Mo-Na Hong et al.
ONCOTARGET (2016)
Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)
B-K Kim et al.
JOURNAL OF HUMAN HYPERTENSION (2016)
Invasive aortic pulse wave velocity as a marker for arterial stiffness predicts outcome of renal sympathetic denervation
Thomas Okon et al.
EUROINTERVENTION (2016)
Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - Exemplified for cardiovascular drugs
Andreas G. Helfer et al.
ANALYTICA CHIMICA ACTA (2015)
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects
Guido Grassi et al.
HYPERTENSION (2015)
Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance
Sebastian Ewen et al.
JOURNAL OF HYPERTENSION (2015)
Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension
Christian Ott et al.
EUROINTERVENTION (2015)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E. Kandzari et al.
EUROPEAN HEART JOURNAL (2015)
Catheter-Based Radiorefrequency Renal Denervation Lowers Blood Pressure in Obese Hypertensive Dogs
Jeffrey R. Henegar et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
Renal Sympathetic Denervation for Treatment of Resistant Hypertension: Egyptian Experience
Mohamed Hamza et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2014)
Anti-hypertensive effect of radiofrequency renal denervation in spontaneously hypertensive rats
Takeshi Machino et al.
LIFE SCIENCES (2014)
The Plasma Renin Test Reveals the Contribution of Body Sodium-Volume Content (V) and Renin-Angiotensin (R) Vasoconstriction to Long-Term Blood Pressure
John H. Laragh et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches
Thomas Unger et al.
EUROPEAN HEART JOURNAL (2011)
Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience
M. Voskuil et al.
NETHERLANDS HEART JOURNAL (2011)
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Murray D. Esler et al.
LANCET (2010)
Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial
Brent M. Egan et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension.
Markus P. Schlaich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
分享论文
